Literature DB >> 28427750

Consensus statements for medical practice: Biological agents and lung disease [Abridged English translation by the Japanese Respiratory Society].

Hitoshi Tokuda1, Masayoshi Harigai2, Hideto Kameda3, Kazunori Tomono4, Noboru Takayanagi5, Akira Watanabe6, Sadatomo Tasaka7, Takafumi Suda8, Kazuhiro Tateda9, Junichi Kadota10.   

Abstract

Entities:  

Keywords:  Airway disease; Biological agent; Interstitial lung disease; Lung complication; Rheumatoid arthritis

Mesh：

Substances：

Year:  2017        PMID： 28427750     DOI： 10.1016/j.resinv.2017.01.002

Source DB:  PubMed          Journal:  Respir Investig        ISSN： 2212-5345


× No keyword cloud information.
  6 in total

Review 1.  Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.

Authors:  Hiroshi Nakase; Motoi Uchino; Shinichiro Shinzaki; Minoru Matsuura; Katsuyoshi Matsuoka; Taku Kobayashi; Masayuki Saruta; Fumihito Hirai; Keisuke Hata; Sakiko Hiraoka; Motohiro Esaki; Ken Sugimoto; Toshimitsu Fuji; Kenji Watanabe; Shiro Nakamura; Nagamu Inoue; Toshiyuki Itoh; Makoto Naganuma; Tadakazu Hisamatsu; Mamoru Watanabe; Hiroto Miwa; Nobuyuki Enomoto; Tooru Shimosegawa; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-04-22       Impact factor: 7.527

2.  Estimation of treatment and prognostic factors of pneumocystis pneumonia in patients with connective tissue diseases.

Authors:  Yuichi Ishikawa; Kazuhisa Nakano; Kei Tokutsu; Hiroko Miyata; Yoshihisa Fujino; Shinya Matsuda; Yoshiya Tanaka
Journal:  RMD Open       Date:  2021-03

3.  Five-year point prevalence survey of healthcare-associated infections and antimicrobial use in a Japanese university hospital.

Authors:  H Morioka; M Iguchi; N Tetsuka; F Kinoshita; Y Tomita; D Kato; A Hirabayashi; A Matsumoto; K Oka; H Kato; T Inagaki; Y Kato; K Kitagawa; K Ichikawa; Y Kouyama; N Kawamura; Y Toyodome; N Adachi; Y Ito; T Yagi
Journal:  Infect Prev Pract       Date:  2021-06-04

Review 4.  Prevention of Infectious Diseases due to Immunosuppression and Vaccinations in Asian Patients with Inflammatory Bowel Disease.

Authors:  Shintaro Sagami; Taku Kobayashi; Toshifumi Hibi
Journal:  Inflamm Intest Dis       Date:  2018-07-17

5.  Development of Rheumatoid Arthritis in Cavitary Mycobacterium avium Pulmonary Disease: A Case Report of Successful Treatment with CTLA4-Ig (Abatacept).

Authors:  Hiromu Tanaka; Takanori Asakura; Jun Kikuchi; Makoto Ishii; Ho Namkoong; Yuko Kaneko; Koichi Fukunaga; Naoki Hasegawa
Journal:  Infect Drug Resist       Date:  2022-01-11       Impact factor: 4.003

6.  Clinical Aspects of Pulmonary Nontuberculous Mycobacteriosis.

Authors:  Hiroshi Moro; Toshiaki Kikuchi
Journal:  Intern Med       Date:  2021-04-12       Impact factor: 1.271
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.